contract development and manufacturing organization (CDMO)
contract development and manufacturing organization (CDMO)
MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬
Game-Changing Cancer Immunotherapy Deal Unveiled
📰 Domain Therapeutics and Chime Biologics join forces to develop an anti-CCR8 antibody for cancer immunotherapy! 👥💉 Exciting times ahead! 🤝
CDMO Incog Supercharges Operations with $75M Expansion
🔧 CDMO Incog gears up with 💰$75m expansion to boost filling capacity. Exciting times ahead! 🚀🔬👩🔬 pharmaceuticals growth
Boost AAV Genome Production with RevIT Enhancer!
🚀 Boost AAV genome production with RevIT™ AAV Enhancer! 🧬💰 Increase titers, streamline workflows, and save costs in gene therapy manufacturing.
Biogen’s CDMO Revenues Set to Plummet!
📢 Biogen, a global biotech company, anticipates a decline in CDMO revenues as its Denmark commitments conclude. 😔
Revolutionary Partnership Expands Cell Therapy Development
📰 Multiply Labs and Thermo Fisher join forces to revolutionize cell therapy production! 💼🔬 Accelerating development and commercialization for patients. 🏭
AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible
📢 AstraZeneca teams up with FasTCAR to fast-track cell therapy production, revolutionizing accessibility and affordability for patients. 🚀
Samsung Biologics and LegoChem unite to revolutionize cancer treatment
🔍 Samsung Biologics teams up with LegoChem to advance ADCs, combining antibodies and drugs to target cancer cells. 🔬 Collaboration leverages manufacturing expertise and ADC development technology for better cancer treatment options.
Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing
📢 Get ready for a game-changer! The Novo Catalent deal is about to shake up the CGT outsourcing space. 💥🧪💼
Evotec’s Breakthrough: Expanding HIV Antibody Deal
📰 Evotec expands anti-HIV antibody deal with ABL to develop and manufacture neutralizing antibodies against HIV. Just-Evotec Biologics to develop third antibody and provide manufacturing services for Phase I clinical study. Partnership aims to deliver new HIV therapies. 💉🌍
